DUBLIN--(BUSINESS WIRE)--The "Global Healthcare Nanotechnology Market - Growth, Trends, and Forecasts 2017 - 2022" report has been added to Research and Markets' offering.
As a market, nanomedicine holds promise owing to its highly precise and reliable nature. Clinical oncology nanomedicine applications dominated the overall market in 2013, however, the cardiovascular nanomedicine market is expected to be the fastest growing segment during the forecast period.
Increasing research funding, growing incidence of cardiovascular diseases, rising geriatric population, awareness of nanomedicine application, high unmet medical needs, and increasing competition by the entry of new players are some of the major drivers for the growth of this market. However, the high costs of nanotechnology-based medical devices and time-consuming product approval are turning out to be restraints for the market.
The applications segment is further segmented into drug delivery, drugs, biomaterials, active implants, in-vitro diagnostics, and in-vivo imaging. Currently, the drug delivery sub-segment holds the larger share as compared to the others because of the higher efficacy of nanomaterials and their ability to cross through the blood with minimum invasiveness and increased bioavailability. This trend is expected to continue throughout the forecast period, as nanoparticles are finding increasing usage in cancer therapy. By disease, the market is sub-segmented into neurological diseases, cardiovascular diseases, oncology, anti-inflammatory, anti-infective, and others, with obesity and diarrhea being the largest sub-segments.
- Abbott Laboratories
- CombiMatrix Corporation
- GE Healthcare
- Sigma-Tau Pharmaceuticals, Inc.
- Johnson & Johnson
- Mallinckrodt PLC
- Merck & Company, Inc.
- Nanosphere, Inc.
- Pfizer, Inc.
- Celgene Corporation
- Teva Pharmaceutical Industries Ltd.
- UCB (Union chimique belge) S.A.
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Global Healthcare Nanotechnology (Nanomedicine) Market -Segmentation
8. Global Healthcare Nanotechnology (Nanomedicine) By Geography - Regional Share and Forecasts
9. Competitive Landscape
10. Company Profiles
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market
For more information about this report visit https://www.researchandmarkets.com/research/8zq7tp/global_healthcare